###begin article-title 0
Tubulointerstitial Macrophage Accumulation is Regulated by Sequentially Expressed Osteopontin and Macrophage Colony-Stimulating Factor: Implication for the Role of Atorvastatin
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 885 886 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1125 1126 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1260 1261 1260 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 357 361 <span type="species:ncbi:10116">rats</span>
Infiltration and local proliferation are known factors that contribute to tubulointerstitial macrophage accumulation. This study explored the time course of these two contributors' roles as tubulointerstitial inflammation and fibrosis progressing, and evaluated the mechanisms of the protective effect of atorvastatin. Unilateral ureteral obstructive (UUO) rats were treated with atorvastatin (10 mg/Kg) or vehicle. Expression of osteopontin (OPN) and macrophage colony-stimulating factor (M-CSF) was evaluated by RT-PCR and immunohistochemistry. Immunohistochemistry staining of ED1 was used to assess macrophage accumulation in interstitium. Histological evaluation was performed to semiquantify tubulointerstitial fibrosis. The results showed that on day 3 after UUO operation, OPN expression significantly increased and positively correlated with the number of the interstitial ED1+ cells, while on day 10, M-CSF expression upregulated and correlated with interstitial ED1+ cells. In atorvastatin treatment group, the increments of these two factors were attenuated significantly at the two time points, respectively. ED1+ cell accumulation and fibrosis also ameliorated in the treatment group. For all the samples of UUO and treatment group on day 10, ED1+ cells also correlated with interstitial fibrosis scores. The results suggest that OPN may induce the early macrophage/monocyte infiltration and M-CSF may play an important role in regulating macrophage accumulation in later stage of UUO nephropathy. Statin treatment decreases interstitial inflammation and fibrosis, and this renoprotective effect may be mediated by downregulating the expression of OPN and M-CSF.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 387 392 <span type="species:ncbi:9606">human</span>
The chronic inflammation characterized by macrophage accumulation in glomeruli and the interstitium is a common feature in most types of glomerulonephritis. Tubulointerstitial macrophage accumulation in particular correlates with kidney disease progression [1]. Indeed, studies have shown that interstitial macrophage accumulation is predictive of disease progression in severe forms of human and experimental glomerulonephritis [2-4]. The accumulated macrophage may directly or indirectly be involved in tubulointerstitial fibrosis [5], which is the hallmark of irreversible chronic kidney injury. So, the study investigating the mechanisms of macrophage accumulation may shed a light on prevention of chronic kidney disease.
###end p 4
###begin p 5
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 266 269 <span type="species:ncbi:10116">rat</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 1357 1365 <span type="species:ncbi:9606">patients</span>
Studies have shown that interstitial macrophage accumulation is due to the results of monocyte/macrophage (M/M) infiltration and local proliferation [6]. Recent study has revealed that osteopontin (OPN) plays an important role in chemotaxis on M/M infiltration in a rat model of anti-GBM glomerulonephritis [7], and macrophage colony-stimulating factor (M-CSF) is a critical factor that induces strong local macrophage proliferation [8, 9]. Although the function of these two cytokines has been identified, which one at which time plays a predominant role remains unclear. Ophascharoensuk et al reported that macrophage influx was less in OPN-/- mice compared to OPN+/+ mice in early stage (day 4 and day 7) in unilateral ureteral obstructive (UUO) nephropathy, but not in later stage (day 14) [10]. Le Meur et al have also found that following UUO, kidney M-CSF mRNA increased in association with local macrophage proliferation in later stage (days 5 and 10). Anti-c-fms (antibody to receptor of M-CSF) treatment caused a minor inhibition of monocyte recruitment at day 1, but reduced macrophage accumulation by 75% at day 10 [11]. Those studies implicate that different cytokines may be responsible for the macrophage accumulation in different phases. However, the study investigating the time course of these two cytokines' expression in a same group of patients/animals is still lacking, so we cannot get an integral interpretation about the time order of these two contributors' roles.
###end p 5
###begin p 6
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 368 371 <span type="species:ncbi:10116">rat</span>
Chronic unilateral ureteral obstruction is a well-characterized experimental model of renal injury leading to tubulointerstitial inflammation and fibrosis [12]. This is because it is normotensive, nonproteinuric, nonhyperlipidemic, and without any apparent immune or toxic renal insult. Studies have shown the prominent M/M accumulation in UUO kidney, so we chose UUO rat as our interstitial inflammation and fibrosis model. Meanwhile, recent studies have revealed that statin can suppress the accumulation of M/M in this experimental kidney disease [13, 14], so we testify the protective effect of atorvastatin and try to investigate the mechanisms of this effect in UUO nephropathy.
###end p 6
###begin title 7
MATERIALS AND METHOD
###end title 7
###begin title 8
Animals and reagents
###end title 8
###begin p 9
###xml 11 30 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
###xml 181 184 <span type="species:ncbi:10116">rat</span>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 214 217 <span type="species:ncbi:10116">rat</span>
###xml 271 275 <span type="species:ncbi:9925">goat</span>
###xml 281 284 <span type="species:ncbi:10116">rat</span>
Adult male Sprague-Dawley rats (180-220 g) were obtained from Experimental Animal Breeding Center of Medical College of Wuhan University. Monoclonal antibodies used were mouse anti-rat ED1 (Serotec Co), mouse anti-rat OPN (National Health Research Institution, USA), and goat anti-rat M-CSF (Santa Cruz Biotech). The primers for OPN, M-CSF, and GAPDH were produced by TaKaRa Co. SPkit was the production of Zymed Co. Atorvastatin was provided by Pfizer Pharmaceutical Ltd.
###end p 9
###begin title 10
Experimental design
###end title 10
###begin p 11
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 11 15 <span type="species:ncbi:10116">rats</span>
###xml 146 149 <span type="species:ncbi:10116">rat</span>
###xml 675 679 <span type="species:ncbi:10116">rats</span>
All the 42 rats were randomly divided into 3 groups as follows: (1) sham-operated group; (2) UUO; (3) UUO+ atorvastatin. The general procedure of rat UUO operation is the same as previously described [15]. After general anesthesia by muscular injection of ketaminum (60 mg/kg body weight), all the animals underwent left proximal ureteral ligation. The left ureter was identified through a suprapubic incision and was ligated with 4.0 silk at two points, and then cut between the two points. Sham operation was done without ureteral ligation and cut. The left kidneys were harvested from the animals at day 3 or 10 after ureteral obstruction operation. At each time point, 7 rats were sacrificed in each group.
###end p 11
###begin p 12
###xml 28 32 <span type="species:ncbi:10116">rats</span>
In UUO+ atorvastatin group, rats were orally administered atorvastatin (10 mg/kg body weight per day) from three days before the UUO operation to the day of sacrifice. For all animals, before removing the kidney, blood samples were obtained from heart, and then centrifuged at 3000 rpm and serum was stored at -70degreesC for later use.
###end p 12
###begin title 13
Morphology
###end title 13
###begin p 14
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Renal tissue at sacrifice was fixed in 10% formalin and embedded in paraffin. For evaluating tubular lesions, sections were stained with PAS reagent. Tubular lesions, characterized by tubular dilation and epithelial desquamation with interstitial expansions, were graded according to the extent of cortical involvement on a scale from 0 to 4 [16]: 0 = normal; 1 = involvement of less than 25% of the cortex; 2 = involvement up to 25% to 50% of the cortex; 3 = involvement up to 50% to 75% of the cortex; 4 = extensive damage involving more than 75% of the cortex. Then they were expressed as tubular injury scores. An observer blinded to the origin of the sections, examined tubulointerstitial fields adjacent to an arbitrary glomerulus at x200. Sections were also stained with Masson trichrome identifying collagen fibers (in blue). Histological assessment of collagen deposition was determined by the point-counting method using a 10x10 grid [17]. A minimum of 10 high power (x400) fields were assessed per animal and results expressed as % total interstital cortical area, excluding glomeruli, blood vessels, and periglomerular and perivascular areas.
###end p 14
###begin title 15
Immunohistochemistry
###end title 15
###begin p 16
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 218 221 <span type="species:ncbi:10116">rat</span>
###xml 296 300 <span type="species:ncbi:9925">goat</span>
###xml 306 309 <span type="species:ncbi:10116">rat</span>
###xml 393 398 <span type="species:ncbi:10090">mouse</span>
###xml 404 407 <span type="species:ncbi:10116">rat</span>
Sections of formalin-fixed, paraffin-embeded tissue were dewaxed, rehydrated, microwaved, and stained using a standard three-layer method as recommended by SP kit. When measuring OPN, the first antibody was mouse anti-rat OPN antibody; when examining the M-CSF expression, the first antibody was goat anti-rat M-CSF antibody; and when measuring macrophage accumulation, the first antibody was mouse anti-rat ED1 antibody. The bound peroxidase was developed with diaminobenzidine to produce a brown colour followed by a blue nuclear haematoxylin counterstain.
###end p 16
###begin title 17
Quantitation of immunohistochemistry
###end title 17
###begin p 18
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The OPN and M-CSF immunostaining was measured by evaluating the labeling index in tubules of the kidney with a computer-assisted image analyzer system (HPIAS-1000) and expressed by integral optical density (IOD). The number of interstitial ED1+ cells was counted in 100 consecutive high-power (x400) fields and expressed as cells per HP.
###end p 18
###begin title 19
Reverse transcriptase-polymerase chain reaction
###end title 19
###begin p 20
###xml 917 922 906 911 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MgCl2</chem-struct>
Total RNA was extracted from kidney tissue using RNAzol BTM (Protech, Inc, USA) according to the manufacturer's instructions. Reverse transcription of 1 mug RNA was performed using 100 pmol random OligA primers (Amersham Pharmacia Biotech, Uppsala, Sweden) and 300 U SuperScript RNAse H (GIBCO BRL) with the mixture of 5 mul buffer, 10 mumol dNTP, 0.1 mmol DTT, and 60 U RNAsin (Boehringer Mannheim, Mannheim, Germany) at 42degreesC for 1 h. PCR was performed using the following primers: OPN: forward primer 5'-GAT GAG TCC TTC ACT GCC AGCA; reverse primer 3'-CGA TAG CAT CCG ACC GCT CTG (amplifying a 418 bp fragment); M-CSF: sense-AGT GAG GGA TTT TTG ACC CAG; antisense-AGA TGA ACC ATC CGT CTT CTC (amplifying a 234 bp fragment); GAPDH: sense-ACC ATG GAG AAG GCT, antisense-AGT GTA GCC CAG GAT (amplifying a 522 bp fragment). PCR of 2 mul of the cDNA was performed with 0.025 U/mul Taq polymerase (GIBCO BRL), 2 mM MgCl2, 0.2 mM dNTP, PCR buffer, and 0.5 muM of each primer in a final volume of 50 mul in a DNA thermocycler 480 (Perkin Elmer, Norwalk, Conn, USA). After 3 min at 94degreesC, PCR was conducted for 30 cycles (pilot studies were performed to ensure that the reaction was within the linear phase) using the following conditions: 455 of denaturation at 94degreesC, 1 min of annealing at 55/57degreesC, and 1 min of extension at 72degreesC, followed by a final extension for 5 min at 72degreesC and cooling to 4degreesC.
###end p 20
###begin p 21
The PCR products were separated by electrophoresis on a 1.5% agarose gel (GIBCO BRL). Following staining with ethidium bromide, the gels were photographed and digitized by using a scanner (Lacie Silver Scanner for Macintosh) and the DeskScan software (Adobe PhotoShop). The image was inverted before performing densitometric analysis by using National Institues of Health Image 1.6 software. A ratio of the intensity between OPN and GAPDH or M-CSF and GAPDH was calculated.
###end p 21
###begin title 22
Measurement of serum lipids
###end title 22
###begin p 23
The serum lipid was tested in our hospital laboratory department. The parameters include total cholesterol, total triglycerol, and HDL-cholesterol.
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 200 201 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 446 447 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Results are present as the mean +/-SD. The number of macrophage, expression of OPN and M-CSF at different time points in three groups, was analyzed by one-way analysis of variance (ANOVA) followed by q test using the SPSS for windows 10.0. In addition, the correlations between macrophage accumulation and cytokines staining or fibrosis index were performed by the Spearman's rank correlation coefficient. Statistical significance was defined as P < .05.
###end p 25
###begin title 26
RESULTS
###end title 26
###begin title 27
Macrophage accumulation
###end title 27
###begin p 28
###xml 18 26 18 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
As illustrated in Figure 1, few macrophages were observed in sham-operated rat kidney. There was a significant increase in the number of interstitial ED1+ cells on day 3 in UUO group and more ED1+ accumulation on day 10. In UUO+ atorvastatin-treated group, interstitial ED1+ macrophage accumulation was markedly decreased on day 3 and day 10 when comparing with UUO animals at the same time points, respectively.
###end p 28
###begin title 29
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Tubulointerstitial injury and fibrosis and correlation with ED1+ cell accumulation
###end title 29
###begin p 30
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 445 453 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 525 526 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
There was marked tubular damage on day 3 and more prominently on day 10 after UUO operation, atorvastatin treatment reduces tubular injury both on day 3 and on day 10 (as shown in Figure 2). To assess tubulointerstitial fibrosis, Masson trichrome staining was performed. The results indicated significantly higher fibrosis score on day 10 in UUO group. The atorvastatin treatment attenuated interstitial fibrosis at that time point (as shown in Figure 3). For all samples of UUO and treated group on day 10, the number of ED1+ interstitial cells significantly correlated with the index of interstitial fibrosis detected by Masson trichrome staining (r = 0.58, P < .01).
###end p 30
###begin title 31
OPN and M-CSF expression and correlation with macrophage accumulation
###end title 31
###begin p 32
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 716 724 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 892 900 892 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1061 1062 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1107 1108 1107 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1117 1118 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1192 1193 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1266 1267 1266 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1276 1277 1276 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The induction of UUO nephropathy led to significantly increased tubular expression of OPN on day 3, but this increase attenuated significantly on day 10. The expression of M-CSF did not upregulate on day 3 but increased and reached statistical significance on day 10. In atorvastatin-treated group, the OPN expression on day 3 and the M-CSF expression on day 10 were significantly ameliorated, respectively, when comparing with UUO group (results are shown in Figures 4 and 5). The reverse transcriptase-polymerase chain reaction (RT-PCR) analysis indicated that the mRNA of OPN on day 3 in UUO group increased by about 13-fold comparing with that of sham group, but decreased to about 9-fold on day 10 (as shown in Figure 6). The expression of M-CSF mRNA was statistically identical to sham group on day 3 and dramatically increased by about 7-fold on day 10 in the UUO group (data shown in Figure 7). When taking all the samples of UUO and UUO+ atorvastatin group on day 3 for correlation analysis, there was a significant positive correlation between the ED1+ cells accumulation and the staining of OPN (r = 0.71, P < .01). When analyzing all samples of these two groups on day 10, the ED1+ cell accumulation was positively correlated with the staining of M-CSF (r = 0.82, P < .01).
###end p 32
###begin title 33
Serum lipid
###end title 33
###begin p 34
###xml 50 57 50 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
Serum lipid level of all the 3 groups is shown in Table 1. As it demonstrated, there was no significant deviation on any time points among these groups.
###end p 34
###begin title 35
DISCUSSION
###end title 35
###begin p 36
The present study demonstrated that in early stage of UUO nephropathy, OPN expression increased and correlated with interstitial macrophage accumulation, while in later stage, M-CSF expression increased and correlated with interstitial macrophage accumulation. Atorvastatin treatment ameliorated the increments of these two cytokines' expression at two time points, respectively, and also reduced the interstitial macrophage accumulation and fibrosis.
###end p 36
###begin p 37
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
Numerous studies have investigated the role of OPN and M-CSF in tubulointerstitial macrophage accumulation [7-9, 18]. Using OPN knockout mice, Persy et al verified that OPN was a critical factor for interstitial macrophage accumulation [19]. Meanwhile, Lenda et al also confirmed that macrophage proliferation was reduced in M-CSF deficient mice [20]. On the contrary to the abundant studies in testing those cytokines' role, only few reports evaluated the time course of these two factors' roles. An integral and comprehensive explanation that temporally considered these two inflammatory mediators is still lacking. The present study identified, to our knowledge for the first time, the pattern of these two cytokines' expression in UUO nephropathy, and provided strong evidence for our postulation that it is the different cytokines that play a predominant role at different time points in macrophage accumulation in UUO nephropathy. Our findings make us reason that OPN and M-CSF are sequentially expressed in tubular cells and regulated interstitial macrophage accumulation in different phases.
###end p 37
###begin p 38
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Our study also indicated that macrophage accumulation correlated with interstitial fibrosis. Although tubulointerstitial inflammation may not be the prerequisite of the onset of interstitial fibrosis [21], and fibrosis cannot be reversed by agents that suppress inflammatory cell activation alone [22], taken together with other studies, our study support that interstitial inflammation may be involved in and accelerate this process. Recent study has also revealed that chemokine receptor antagonist reduce interstitial inflammation and fibrosis [3, 23]. All those reports underline the recognition that macrophage accumulation could be considered as a major component involved in the tubulointerstitial fibrosis.
###end p 38
###begin p 39
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
Statins (HMG-CoA reductase inhibitor) have been shown to inhibit macrophage accumulation in tubulointerstitium independent of their cholesterol-lowering effects [24]. This study demonstrated that atorvastatin reduced the number of macrophage on day 3 and on day 10 after UUO operation through downregulating the expression of OPN and M-CSF independent of cholesterol-lowering effects. We suppose that this may be the mechanistic insight that explains how atorvastatin exerts this anti-inflammation effect. Studies also have shown that atorvastatin downregulates the expression of adhesion molecule in endothelial cells [25], which is also related to macrophage accumulation. In UUO nephropathy, atorvastatin reduces OPN expression which may also be related to its inhibiting effect on angiotensin II [26], because studies have shown that angiotensin II is a potent inducer of OPN [18]. On the other hand, atorvastatin also can inhibit NF-kappa B activation [13]. This effect may be related to its role in downregulating M-CSF expression [27]. But, all these presumptions need more studies to investigate because of the complicated interaction of these cytokines in vivo.
###end p 39
###begin p 40
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
In our study, atorvastatin significantly reduced interstitial fibrosis. This effect may be related to its role in reducing macrophage accumulation as this study identified, but it may also be related to its pleiotrophic effect on other fibrogenic factors. As we discussed above, macrophage may not be the only contributor to interstitial fibrosis, blockade of the angiotensin II type 2 receptor can also suppress interstitial fibrosis without affecting interstitial macrophage accumulation [28]. As statin holds the capacity of inhibiting angiotensin II [13], we guess that atorvastatin can also reduce fibrosis independent of its role in reducing macrophage accumulation.
###end p 40
###begin p 41
###xml 106 109 <span type="species:ncbi:10116">rat</span>
In summary, this study has demonstrated that OPN and M-CSF expression was upregulated in tubular cells in rat UUO nephropathy in different phases, and correlated with local macrophage accumulation at related time points. Atorvastatin may decrease macrophage accumulation through inhibiting OPN and M-CSF expression, and finally ameliorate the interstitial fibrosis.
###end p 41
###begin title 42
ACKNOWLEDGMENTS
###end title 42
###begin p 43
The authors are grateful to Dr Layuan Xiong and Dr Hongxia Yang, Laboratory Center of Nephrology, for their expert technical assistance. They thank Dr Shiquan Liu for many helpful discussions.
###end p 43
###begin article-title 44
Progression in chronic kidney disease
###end article-title 44
###begin article-title 45
Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study
###end article-title 45
###begin article-title 46
###xml 122 126 <span type="species:ncbi:10090">mice</span>
Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice
###end article-title 46
###begin article-title 47
Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy
###end article-title 47
###begin article-title 48
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity
###end article-title 48
###begin article-title 49
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Local macro-phage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis
###end article-title 49
###begin article-title 50
Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis
###end article-title 50
###begin article-title 51
Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation
###end article-title 51
###begin article-title 52
###xml 83 88 <span type="species:ncbi:9606">human</span>
Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis
###end article-title 52
###begin article-title 53
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis
###end article-title 53
###begin article-title 54
Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway
###end article-title 54
###begin article-title 55
Obstructive nephropathy and renal fibrosis
###end article-title 55
###begin article-title 56
Statins: effects beyond cholesterol lowering
###end article-title 56
###begin article-title 57
Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction
###end article-title 57
###begin article-title 58
Plasmin is not protective in experimental renal interstitial fibrosis
###end article-title 58
###begin article-title 59
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy
###end article-title 59
###begin article-title 60
Transforming growth factor-beta1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction
###end article-title 60
###begin article-title 61
Expression, roles, receptors, and regulation of osteopontin in the kidney
###end article-title 61
###begin article-title 62
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice
###end article-title 62
###begin article-title 63
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation
###end article-title 63
###begin article-title 64
###xml 99 103 <span type="species:ncbi:10116">rats</span>
Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats
###end article-title 64
###begin article-title 65
A(2A) adenosine receptor agonist and PDE(4) inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy
###end article-title 65
###begin article-title 66
###xml 64 68 <span type="species:ncbi:10090">mice</span>
CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome
###end article-title 66
###begin article-title 67
###xml 101 105 <span type="species:ncbi:10116">rats</span>
Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction
###end article-title 67
###begin article-title 68
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia
###end article-title 68
###begin article-title 69
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure-and cholesterol-lowering effects
###end article-title 69
###begin article-title 70
###xml 20 21 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Nuclear factor kappaB for the nephrologist
###end article-title 70
###begin article-title 71
Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis
###end article-title 71
###begin p 72
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 63 0 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ED1<sup>+</sup> cell accumulation at different time points in three groups</italic>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ED1+ cell accumulation at different time points in three groups (x400). Sections were stained using a standard three-layer method as recommended by SP kit. Macrophage accumulation was measured by immunohistochemistry and quantified by the number of ED1+ cells/HP: (a) sham group, (b) UUO on day 3, (c) UUO on day 10, (d) treatment group on day 3, and (e) treatment group on day 10. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 72
###begin p 73
###xml 0 61 0 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tubular injury score at different time points in three groups</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Tubular injury score at different time points in three groups (x100). Sections were stained with PAS regent. Tubular lesions were graded according to the extent of cortical damage: (a) sham group, (b) UUO on day 3, (c) UUO on day 10, (d) treatment group on day 3, and (e) treatment group on day 10. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 73
###begin p 74
###xml 0 68 0 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tubulointerstitial fibrosis at different time points in three groups</italic>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Tubulointerstitial fibrosis at different time points in three groups (x200). Sections were stained with Masson trichrom identifying collagen fibers. Collagen deposition was determined by the point-counting method: (a) sham group, (b) UUO on day 3, (c) UUO on day 10, (d) treatment group on day 3, and (e) treatment group on day 10. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 74
###begin p 75
###xml 0 60 0 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staining of OPN at different time points in different groups</italic>
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Staining of OPN at different time points in different groups (x200). Using antibody against OPN, sections were stained by immunohistochemistry. Labeling index was expressed by integral optical density (IOD): (a) sham group, (b) UUO on day 3, (c) UUO on day 10, (d) treatment group on day 3, and (e) treatment group on day 10. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 75
###begin p 76
###xml 0 86 0 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staining of M-CSF at different time points in different groups by immunohistochemistry</italic>
###xml 358 359 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 412 413 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Staining of M-CSF at different time points in different groups by immunohistochemistry (x200). Using antibody against M-CSF, sections were stained by immunohistochemistry. Labeling index was expressed by integral optical density (IOD): (a) sham group, (b) UUO on day 3, (c) UUO on day 10, (d) treatment group on day 3, and (e) treatment group on day 10. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 76
###begin p 77
###xml 0 73 0 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of OPN at different time points in different groups by RT-PCR.</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Expression of OPN at different time points in different groups by RT-PCR. Total RNA was extracted from kidney tissue at the indicated time and reverse-transcribed to cDNA. cDNA was subject to PCR, and OPN was amplified to 418 bp fragments. GAPDH was used as internal control (a) on day 3 in sham group, (b) on day 10 in sham group, (c) on day 3 in UUO group, (d) on day 10 in UUO group, (e) on day 3 in treatment group, and (f) on day 10 in treatment group. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 77
###begin p 78
###xml 0 75 0 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of M-CSF at different time points in different groups by RT-PCR.</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Expression of M-CSF at different time points in different groups by RT-PCR. Total RNA was extracted from kidney tissue at the indicated time and reverse-transcribed to cDNA. cDNA was subject to PCR, and M-CSF was amplified to 234 bp fragments. GAPDH was used as internal control (a) on day 3 in sham group, (b) on day 10 in sham group, (c) on day 3 in UUO group, (d) on day 10 in UUO group; (e) on day 3 in treatment group, and (f) on day 10 in treatment group. **: P < .01 versus sham group of the same time point. ##: P < .01 versus UUO group of the same time point.
###end p 78
###begin p 79
Serum lipid level at different time points of different groups.
###end p 79

